Synthesis and Human β-Adrenoceptor Activity of 1-(3,5-Diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol Derivatives in Vitro-Reference-Cited by-同舟云学术

Synthesis and Human β-Adrenoceptor Activity of 1-(3,5-Diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol Derivatives in Vitro

Published:2000-02-01 Issue:4 Volume:43 Page:591-598
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

He Yali¹,Nikulin Victor I.¹,Vansal Sandeep S.¹,Feller Dennis R.¹,Miller Duane D.¹

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee−Memphis, Memphis, Tennessee 38163, and Department of Pharmacology, National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi 38677

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm990463j

Reference37 articles.

1. New prospects in old bubbles

2. Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical ‘β3-adrenoceptor?’

3. Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species

4. Evidence for a functional β3-adrenoceptor in man

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemical constituents from the seeds of Calycotome villosa subsp. intermedia;Arabian Journal of Chemistry;2017-05

2. Orthorhombic polymorph of (6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methanol;Acta Crystallographica Section E Structure Reports Online;2011-06-18

3. ChemInform Abstract: Synthesis and Human β-Adrenoceptor Activity of 1-(3,5-Diiodo-4-methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol Derivatives in vitro.;ChemInform;2010-06-08

4. Recent Advances in Identification and Characterization of β-Adrenoceptor Agonists and Antagonists;Current Topics in Medicinal Chemistry;2007-01-01

5. Anti-obesity Activity;Drug Discovery and Evaluation;2007